Global Lip Augmentation Market 2022-2028

Global Lip Augmentation Market 2022-2028

Lip augmentation is a cosmetic procedure that aims to increase lip fullness through enlargement using fillers such as hyaluronic acid, fat or implants. Between various dermal fillers, HA is the most commonly used because it is considered safe and effective. According to market research study published by Gen Consulting Company, the global lip augmentation market stood at around USD 2,043 million in 2021 and is projected to rise to a worth of USD 3,434 million by 2028 end, thereby garnering a CAGR of 7.7% during 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global lip augmentation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the lip augmentation industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, product, and region. The global market for lip augmentation can be segmented by type: permanent, temporary. Lip augmentation market is further segmented by product: fat injection/lipo-injection, hyaluronic acid fillers, lip collagen, poly-l-lactic acid fillers, others. The hyaluronic acid fillers segment captured the largest share of the market in 2021. Based on region, the lip augmentation market is segmented into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

• permanent
• temporary

By product:

• fat injection/lipo-injection
• hyaluronic acid fillers
• lip collagen
• poly-l-lactic acid fillers
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The global lip augmentation market report offers detailed information on several market vendors, including Abbvie Inc. (Allergan plc), Galderma Pharma S.A., Laboratories Vivacy SaS, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Limited (Huadong Medicine Co., Ltd.), Suneva Medical, Inc., Teoxane SA, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global lip augmentation market.
• To classify and forecast the global lip augmentation market based on type, product, region.
• To identify drivers and challenges for the global lip augmentation market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global lip augmentation market.
• To identify and analyze the profile of leading players operating in the global lip augmentation market.

Why Choose This Report

• Gain a reliable outlook of the global lip augmentation market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.